Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × avelumab × 30 days × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 4 Carcinoma, Transitional Cell 4 Urethral Neoplasms 2 Ureteral Neoplasms 2 Neoplasm Metastasis 2 Carcinoma, Renal Cell 2 Carcinoma, Merkel Cell 2 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Osteosarcoma 1 Metastatic Urothelial Cancer 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Melanoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 10 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 7 fludarabine 6 fludarabine phosphate 3 Specimen Handling 3 Rituximab 3 Magnetic Resonance Spectroscopy 3 zanubrutinib 2 polatuzumab vedotin 2 pirtobrutinib 2 obinutuzumab 2 glofitamab 2 Leukapheresis 2 Biopsy 2 tazemetostat 1 tafasitamab 1 pomalidomide 1 loncastuximab tesirine 1 ibrutinib 1 decitabine and cedazuridine drug combination 1 belinostat 1 axicabtagene ciloleucel 1 X-Rays 1 Vincristine 1 Prednisone 1 Pharmacokinetics 1 Pharmacogenomic Variants 1 Phantoms, Imaging 1 Nivolumab 1 MLN 8237 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡